C.R. Bard scored FDA approval for its Lutonix drug-coated balloon to treat a complication of end-stage renal disease.

The FDA approved the integration of Tandem's touchscreen insulin pump and Dexcom's G5 CGM.

Creo designed the device to enable the minimally invasive removal of lesions from the bowel.

The device is designed to enable early detection of artery disease by visualizing energy distribution during cardiac cycles.

The FDA updated its warning on liquid-filled intragastric balloons used to treat obesity after receiving five new reports of patient deaths.

Abbott has enrolled the first patient in a clinical study to investigate its clip-based system as a treatment for leaky tricuspid valves.

Stimwave scored FDA clearance for its tiny, injectable, MRI-safe neurostimulator for chronic peripheral nerve pain.

Doctors can use the software and accompanying optical coherence tomography device to automatically assess the thickness of the epithelia and stroma.